ABSTRACT: Racemic 1-hydroxy-3-butenyl-, 3-chloro-1-hydroxypropyl-, and 3-bromo-1-hydroxypropylphosphonate and the corresponding (S)-enantiomers obtained by lipasecatalyzed resolution of the respective racemic chloroacetates were subjected to functional group manipulations. These comprised ozonolysis, Mitsunobu reactions with hydrazoic acid and N-hydroxyphthalimide, alkylation of hydrazine derivative, removal of phthaloyl group followed by intramolecular substitution, and global deprotection to deliver the racemates and (R)-enantiomers (ee 92−99% by chiral high-performance liquid chromatography) of pyrrolidin-2-yl-, oxazolidin-3-yl-, oxazolidin-5-yl-, pyrazolidin-3-yl-, and 1,2-oxazinan-3-ylphosphonic acids. These phosphonic acids were evaluated as analogues of proline and proline analogues for the ability to inhibit γ-glutamyl kinase, δ 1 -pyrroline-5-carboxylate synthetase, and δ 1 -pyrroline-5-carboxylate reductase. Only the latter enzyme was inhibited by two of them at concentrations exceeding 1 mM.
■ INTRODUCTION
Herbicides with favorable properties such as high activity, crop tolerance, and low toxicity to insects and mammals are essential for weed control in modern agriculture to secure food supply for the growing world population. 1 Furthermore, persistence of these agrochemicals should be minimal and biodegradation by the soil microflora should be complete in a short time span. Rapid development of resistant weeds in combination with diffusion of the acquired resistance in the biosphere is a public concern and has forced companies to search for new herbicide targets and active ingredients. Amino acid metabolism is an attractive target for herbicide development. 2 However, little attention has so far been paid to interference with proline biosynthesis. It is accessed by two routes, the ornithine and glutamate pathways, the latter being the main one in plants. Both the pathways share the last reaction step catalyzed by the NAD(P)H-dependent δ 1 -pyrroline-5-carboxylate (P5C) reductase. 3 Luckily, this fact allows to block both ways with only one inhibitor. Forlani and Kafarski et al. found that N-phenyl-substituted aminomethylenebisphosphonic acids are inhibitors of P5C reductase with activity in the micromolar to millimolar range. 4−6 These compounds also demonstrated phytotoxicity in vivo, which could be reversed by exogenously supplied amino acids. 7 We reasoned that phosphonic acid analogues of L-proline and proline analogues could be inhibitors of the reductase and other enzymes in the proline metabolism. To test this idea, a series of racemic, chiral nonracemic, and achiral phosphonic acids were synthesized for evaluation first with P5C reductase of plants ( Figure 1 ). The selection of compounds comprised five-(1−4) and six-membered (5 and 6) ring systems with one or two heteroatoms, all with an attached phosphonic acid group. The (R)-configured enantiomers of 1−6 correspond to the (S)-or Lconfigured ones in the carboxyl acid series because of the higher priority of PO 3 H 2 compared to CO 2 H according to the Cahn− Ingold−Prelog rules. Many azaheterocyclic phosphonates have been synthesized and biologically evaluated in the past. 8 
■ RESULTS AND DISCUSSION
Synthesis of (±)-, (R)-, and (S)-Phosphaproline. Although racemic, (R)-, and (S)-phosphaproline [(±)-, (R)-, and (S)-1] have been described in the literature, 9−17 we present here a new access from recently prepared racemic and enantiomeric 1-hydroxy-3-butenylphosphonate 7 (Scheme 1). 18 It also served as a starting material for phosphonic acids racemic 2 and 6. Hydroxyphosphonate (±)-7 was resolved by lipase-catalyzed kinetic hydrolysis of the chloroacetic ester and delivered the enantiomers with ee >97%. 18 The enantiomer (S)-7 was transformed into (R)-1, (R)-2, and (R)-6 and the enantiomer (R)-7 into phosphaproline (S)-1 by functional group manipulation. Furthermore, (±)-and (S)-7 were already converted to phosphaaspartic acids via azides (±)-and (S)-8 prepared by Mitsunobu reaction. 18 Evans and Weber 19 and later others 20, 21 described the formation of pyrrolidines from homoallyl azides upon hydroboration with dicyclohexylborane. As we hoped that azides 8 prepared by the Mitsunobu reaction 18, 22 would undergo the same cylization, we reacted them with dicyclohexylborane. 23 Trialkylboranes 9 were unstable and underwent migration of an alkyl group from the boron to nitrogen atom, with loss of nitrogen after attack of the azido group on the boron atom. 19 The phosphaproline derivatives 10 were globally deprotected by refluxing 6 M HCl. Phosphaprolines 1 were isolated by cation-exchange chromatography (Dowex 50W × 8, H + ) and crystallized. The enantiomers of 8 delivered the enantiomers of 1 of known configuration, correctly assigned 17 recently. The ee of (R)-and (S)-1 was the same (>99%) as that of the starting α-hydroxyphosphonates 7 (>99%), which was proven by chiral high-performance liquid chromatography (HPLC) ( Figure S1 ).
Synthesis of (±)-and (R)-Isoxazolidin-3-ylphosphonic Acid. These phosphonic acid analogues of structural analogues of proline were obtained by functional group manipulation of (±)-and (S)-11 18 (Scheme 2). Ozonolysis gave both hydroxyphosphonates 12 in 91% yield. The following Mitsunobu reaction 22 with N-hydroxyphthalimide delivered protected Oalkylhydroxylamines (±)-and (S)-13 in yields of 83 and 84%, respectively. Hydrazinolysis in iPrOH effected removal of the phthaloyl group. The open-chain O-alkylhydroxylamines (±)-and (S)-14 with a leaving group at C-1 immediately cyclized to isoxazolidin-3-ylphosphonates 15. As the 4-nitrobenzenesulfonyloxy (nosyloxy) group was replaced with inversion of configuration, the (S)-enantiomer of 13 was transformed into (R)-15. The crude isoxazolidin-3-ylphosphonates 15 were deprotected with HBr in AcOH at room temperature in 16 h. 24 The phosphonic acids were purified by cation-exchange chromatography (Dowex 50W × 8, H + ) and crystallization. The overall yields of (±)-and (R)-2 25 starting from 13 were 79 and 74% (ee 99%, Figure S2 ), respectively. Surprisingly, deprotection of 15 with bromotrimethylsilane (TMSBr)/allyltrimethylsilane (allylTMS) 26 had a detrimental effect on the yield of (R)-2 (15%).
Synthesis of Phosphapipecolic Acid (±)-5 and (±)-and (R)-1,2-Oxazinan-3-ylphosphonic Acid [(±)-and (R)-6].
Phosphonic acids 5 and 6 differ from phosphaproline by replacing the five-membered ring by a six-membered ring containing an additional CH 2 group or an oxygen atom. The preparation of racemic phosphapipecolic acid was recently published. 14 The synthesis of analogues 6 was accomplished starting from 4-hydroxybutylphosphonates 16, derived from nosylates (±)-and (S)-11 (ee 85%) by hydroboration with H 3 B × tetrahydrofuran (THF), followed by oxidative cleavage of the B−C bond with H 2 O 2 /NaHCO 3 (Scheme 3). 18 The Mitsunobu reaction and the ensuing cyclization induced by hydrazine hydrate were similarly performed for the transformation of 12 into 15 in Scheme 2 and delivered 1,2-oxazinanes (±)-and (R)-18, cyclic oxime ethers. 27 However, this time the hydroxylamine derivatives, the two 1,2-oxazinan-3-ylphosphonates (±)-and (R)-18, were first isolated as homogeneous compounds by flash column chromatography, fully characterized and finally depro- tected. Although the five-membered analogue 15 suffered partial decomposition on attempted deprotection with refluxing 6 M HCl, 1,2-oxazinan-3-ylphosphonates (±)-and (R)-18 were smoothly deprotected, as evidenced by their high yields of 94 and 91%, respectively. The ee of 83% for phosphonic acid (R)-6 was increased to 92% upon crystallization from H 2 O/EtOH ( Figure  S5 ).
ACS Omega
Synthesis of (±)-and (R)-(+)-Isoxazolidin-5-ylphosphonic Acid [(±)-and (R) -3] . For the preparation of these heterocyclic phosphonic acids, isomeric to (±)-and (R)-2, a separate entry had to be developed (Scheme 4). We reasoned that racemic 3-chloro-1-hydroxypropylphosphonate (±)-20 could be the key intermediate for both isoxazolidin-5-ylphosphonic acids, as it could be easily prepared as racemate and resolved enzymatically. Ethyl β-chloropropionate (19) was reduced to the aldehyde with diisobutylaluminium hydride (DIBALH) in dry toluene at −78°C, to which diisopropyl trimethylsilyl phosphite was added to give α-hydroxyphosphonate (±)-20 in 84% yield in a one-pot reaction. 28 Chloroacetylation with (ClH 2 CC(O)) 2 O/pyridine furnished α-chloroacetoxyphosphonate (±)-21. This ester was subjected 14 to lipasecatalyzed kinetic hydrolysis in a biphasic system on a preparative scale with 16.3 mmol of substrate. When the enzymatic hydrolysis was stopped at 40% conversion, 5.14 mmol of α-hydroxyphosphonate (+)-20 with an ee of 97% and (S)-configuration were obtained, determined 28, 29 by using (R)-(+)-t-Bu(Ph)P(O)SH as the chiral solvating agent in combination with 31 P nuclear magnetic resonance (NMR) spectroscopy. Satisfyingly, α-hydroxyphosphonates (±)-and (S)-20 were converted to N-protected O-alkylhydroxylamines (±)-and (R)-22 in yields of 88 and 72% (ee 95% by HPLC, Figure S6 ), respectively. Luckily, the chloride on the primary C-3 position was a much weaker leaving group than Ph 3 PO and did not compete with the displacement reaction at C-1. The cleavage of the phthaloyl group was again induced with hydrazine hydrate. Precursors 22 were cyclized to isoxazolidin-5-ylphosphonic acids (±)-and (R)-23, which were directly used for the next step. Global deprotection was accomplished as outlined above. The overall yields of (±)-and (R)-3 starting from 23 were 81 and 63% (ee 97%, Figure S3 ), respectively. The crystalline isoxazolidinylphosphonic acids 2 and 3 had to be stored at −18°C to prevent gradual decomposition at room temperature.
Synthesis of (±)-and (R)-(−)-Pyrazolidin-3-ylphosphonic Acids [(±)-and (R) -4] . Initially, we reasoned that these phosphonic acids could easily be prepared by the reaction of a modified propylphosphonate, with leaving groups at C-1 and C-3, with a protected hydrazine derivative, but were convinced of the contrary. At first, 3-chloro-1-hydroxypropylphosphonate (±)-20 was converted to triflate (±)-24 in 71% yield (Scheme 5). It was added to a mixture of N,N′-bis(Boc)-hydrazine 31 and NaH in dimethylformamide (DMF), which had been stirred for 30 min at room temperature and was allowed to react for 18 h at 20°C and 2 h at 50°C. The crude product, which did not contain the starting material, was a complex mixture and was therefore discarded. The failure of this experiment was attributed to a combination of the low reactivity from Cl − as the leaving group at C-3 and the high reactivity 32 of TfO − at C-1. The first step, that is, the intermolecular reaction of the deprotonated hydrazine derivative will prefer attack at C-3. The cyclization of the Nsubstituted hydrazine intermediate should easily proceed to pyrazolidin-3-ylphosphonate (±)-25, as it is an intramolecular process, and TfO − is an excellent leaving group. Substitution at C-1 of phosphonates was first considered unlikely for steric reasons and low reactivity in general. The size of the attacking nucleophile and the shielding of C-1 by the isopropyl-protecting groups at the phosphorus atom disfavor a S N 2 reaction. Baseinduced elimination of TfOH was more likely than substitution. Consequently, a better leaving group had to be placed at C-3 or/ and a less reactive one at C-1.
To replace chloride by bromide, β-bromopropionate 26 was transformed into 3-bromo-1-hydroxyphosphonate (±)-29 and then into bromo triflate (±)-30a by the same procedures as used for the chloro derivative (Scheme 6). It was reacted with N,N′-bis(Boc)-hydrazine in a biphasic system 33 (20% NaOH/toluene) under phase-transfer conditions at room temperature. The extractively obtained crude product was again a complex mixture without a starting material, but contained elimination products as judged by NMR spectroscopy. As found later, when we had compound (±)-25 in hand, this mixture already contained some of it. Importantly, this experiment demonstrated that the trifluoromethanesulfonyloxy group had to be replaced by a less reactive leaving group such as a mesyloxy or 4-nitrobenzenesulfonyloxy (nosyloxy) group to interfere with elimination. The corresponding mesylate (±)-28b and nosylate (±)-28c were obtained in 93 and 86% yield, respectively, by esterification of 3-bromo-1-hydroxyphosphonate (±)-27 with mesyl chloride/ Et 3 N or NosCl/Et 3 N/dimethylaminopyridine (DMAP) (Scheme 6). When the experiment with bis(Boc)-hydrazine/ NaOH was repeated with mesylate (±)-28b instead of the triflate at 0°C and followed by thin-layer chromatography (TLC) monitoring, no new product could be detected besides the starting material after a reaction time of 1 h. Then, the temperature was increased to 19−20°C. After 1 h, a spot of a new compound less polar than the substrate appeared on the TLC plate, and its intensity increased with the reaction time. After 5 h at 19−20°C, the reaction mixture was worked up. The 31 P NMR spectrum of the crude product displayed resonances for the cyclic phosphonate (±)-25, the open chain product (±)-29b, a compound of unknown structure, and the starting material (±)-28b in molar ratios of 4:100:16:1. Flash column chromatography gave the open chain hydrazine derivative (±)-29b in 75% yield as a colorless gum. As expected, the first substitution occurred at C-3, and the second one at C-1 virtually did not take place at 20°C. When hydrazine derivative (±)-29b was heated at 80°C under the same reaction conditions as before except for the higher reaction temperature, cyclization smoothly proceeded to pyrazolidine (±)-25 and was finished after 2.5 h. Workup and purification delivered pyrazolidin-3-ylphosphonate (±)-25 in 75% yield. The reaction with nosylate (±)-29c was performed analogously (56% yield) except that the reaction temperature for both steps was 50°C instead of 20°C at the beginning and 80°C later, owing to the nosyloxy group being a better leaving group than the mesyloxy one. When cyclization was carried out in DMF with KOtBu as the base for 1.5 h at 0°C and 1.5 h at 20°C, the yield was somewhat higher (65%). The yield could not be improved any further despite many experiments. It seemed likely that the partial removal of an isopropyl group would give a water-soluble salt and thus decrease the yield. Global deprotection of (±)-25 was more sensitive to forcing conditions such as refluxing 6 M HCl than to the milder conditions with TMSBr/allylTMS at 50°C. Purification of the crude product by cation-exchange chromatography (Dowex 50W × 8, H + ) and crystallization furnished racemic pyrazolidin-3-ylphosphonic acids [(±)-4] in 55% yield.
To prepare its enantiomer (R)-4, bromohydroxyphosphonate (±)-27 was chloroacetylated and kinetically resolved in the same way as the chloro analogue (±)-21 (Scheme 7). Stopping hydrolysis at a conversion of 40% delivered (+)-α-hydroxyphosphonate (S)-27 of 95% ee, as determined via (R)-Mosher ester in combination with 31 P NMR spectroscopy. This enantiomer was nosylated (ee 95% by HPLC, Figure S7 ) and then cyclized with inversion of configuration at C-1 in analogy to the racemate in a basic biphasic system mediated by a phasetransfer catalyst at 50°C. Global deprotection of (R)-25 delivered pyrazolidin-3-ylphosphonic acid [(R)-4, ee 92%, Figure S4 ] by isolation from the crude product as for the racemate.
Inhibition of Plant P5C Reductase by Phosphonic Acid Analogues of Proline and Proline Analogues. The ability of all obtained compounds to interfere with the catalytic activity of P5C reductase, purified from Arabidopsis thaliana cultured cells, 34 was then evaluated. In the range from 10 −4 to 10 −3 M, their addition to the assay mixture was found ineffective. On the contrary, when millimolar concentrations of compounds (R)-, (S)-1, and(R)-6 were used, a significant inhibition was evident that was proportional to the dose ( Figure 2 ). Interestingly, their effectiveness was higher than that of proline, which exerts product inhibition in the range from 10 to 200 mM. 34, 35 The calculated IC 50 values were 84 ± 3, 24 ± 4, 21 ± 2, and 45 ± 19 mM for proline, (R)-, (S)-1, and (R)-6, respectively. However, these concentrations were 3−4 orders of magnitude higher than those found for bisphosphonate inhibitors of P5C reductases from higher plants. 4−7 Therefore, although potentially useful for molecular-docking studies aimed at a better comprehension of the product inhibition mechanism, the use of these analogues for weed control seems unfeasible. The ability of phosphonic acid analogues of proline and proline analogues to interfere with the activity of the enzymes that catalyze the first step in proline biosynthesis in bacteria and plants, namely γ-glutamyl kinase and P5C synthetase from Escherichia coli and rice, respectively, was also assessed. However, in no case was their catalytic rate significantly inhibited (data not shown). 
■ CONCLUSIONS
In summary, we have prepared the racemic 1-hydroxy-3-butenyl-, 3-chloro-1-hydroxypropyl-, and 3-bromo-1-hydroxypropylphosphonate and converted them to chloroacetates for lipasecatalyzed enantioselective hydrolysis. The racemates and (S)-enantiomers of these α-hydroxyphosphonates were transformed into racemic and (R)-configured pyrrolidin-2-yl-, oxazolidin-3-yl-, oxazolidin-5-yl-, pyrazolidin-3-yl-, and 1,2-oxazinan-3-ylphosphonic phosphonic acids by a variety of functional group manipulations. The ee (92−99%) of the (R)-enantiomers were determined after derivatization using chiral HPLC on quinine and quinidine-derived anion-exchange columns. These phosphonic acids, structural analogues of proline and proline analogues, were tested as P5C reductase inhibitors, but displayed negligible activity. They also did not interfere with the enzymes of bacteria and plants catalyzing the first step in proline biosynthesis. These phosphonic acids may also be evaluated as inhibitors of proline-metabolizing enzymes. (85%; δ P 0.00) and coupling constants (J) in Hz. Infrared (IR) spectra were recorded on a Bruker VERTEX 70 IR spectrometer in the attenuated total reflection (ATR) mode or of films on a silicon disc. 36 High-resolution mass spectra (HRMS) were obtained using a Brucker Maxis Q-TOF mass spectrometer [electrospray ionization (ESI)]. Optical rotations were measured on a PerkinElmer 341 polarimeter in a 1 dm quartz cell. Analytical HPLC: Shimadzu system comprising components LC-20AT, SIL-20A HT, CTO-20AC, SPD-20A, CMB-20A, column: CHIRALPAK IA (250 mm × 4.6 mm, particle size 5 μm, 1 mL/min, 25°C). Melting points were measured on a Leica Galen III Thermovar instrument and are uncorrected.
■ EXPERIMENTAL SECTION
Anhydrous THF was refluxed over potassium and distilled prior to use. Pyridine was dried by refluxing over powdered CaH 2 , then distilled, and stored over molecular sieves (4 Å). All other solvents, also dry ones, and chemicals were used as purchased. Flash column chromatography was performed using silica gel (particle size 0.040−0.063 mm). Reactions were monitored by analytical TLC using precoated silica gel plates (60 F 254 , 250 μm thickness). Spots were visualized by ultraviolet (UV) and/or dipping into a solution of (NH 4 ) 6 Mo 7 O 24 ·4H 2 O (25.0 g) and Ce(SO 4 ) 2 ·4H 2 O (1.0 g) in 10% aqueous H 2 SO 4 (500 mL), followed by heating with a heat gun. The solvent for TLC of phosphonic acids was iPrOH/H 2 O/NH 3 (25%) in the ratio of 6:3:1. Spots of phosphonic acids were visualized by dipping the silica gel plate into a solution of 2% ninhydrin in EtOH and heating with a heat gun.
Determination of Enantiomeric Excesses of Aminophosphonic Acids. The analytical determination of enantiomeric excesses was performed with a commercial CHIRALPAK tert-butyl-QD-AX (150 mm × 4 mm, 5 μm) column and an inhouse prepared underivatized OH-QN-AX column 37 (150 mm × 4 mm, 5 μm; CSP1). The mobile phase comprised an aqueous H 3 PO 4 solution in MeOH in the ratio of 1:9 (v/v). Note that the molarity of the aqueous phase as well as the apparent pH (adjusted with triethylamine) of the polar organic mobile phase and the flow rates were optimized depending on the amino phosphonic acid, the column type, and the derivatization type. These chromatographic conditions are provided in the respective figure legends of the corresponding chromatograms summarized in the Supporting Information.
The instrumentation used were a thermoshaker PHMT with PSC24N from Grant-bio (Cambridgeshire, UK) and an Agilent 1100 HPLC−UV−fluorescence detector (FLD) system from Agilent (Waldbronn, Germany), which comprised a binary pump, a temperature controlled column oven, an autosampler, a multiwavelength detector (MWD) and a FLD. For the FLD, a gain of 10, an excitation wavelength of 254 nm, and an emission wavelength of 395 nm were chosen, whereas the MWD was set to 254 nm.
For compounds 1 and 2, a derivatization with the Sanger's reagent (1-fluoro-2,4-dinitrobenzene, DNFB from Sigma Aldrich) and chiral separation on the CHIRALPAK tert-butyl-QD-AX column were chosen. For compounds 3, 4, and 6, a derivatization with 6-aminoquinolyl-N-hydroxysuccinimidyl carbamate (AQC from Synchem) and chiral separation on an underivatized OH-QN-AX column provided the best results.
AQC Derivatization. Phospha amino acid (10 μL, 20 mM in water) was added to 0.2 M borate buffer (pH 8.8, 70 μL), followed by the addition of AQC (3 mg/mL in dry acetonitrile, 20 μL). The reaction mixture was immediately heated at 55°C for 10 min.
DNFB Derivatization. To a solution (150 μL, 10 mM) of phospha amino acid in sodium carbonate buffer (0.1 M, pH 9.5), Sanger reagent [2.5% (v/v) in acetonitrile, 50 μL] was added and heated for 15 min at 50°C. After reaching room temperature and centrifugation, the respective mobile phase (350 μL) was added.
Chromatographic results are summarized in the Supporting Information in Figure S1 Note that for DNFB-derivatized compounds 1 and 2, an elution order of the (S)-enantiomer before the (R)-enantiomer was observed on the CHIRALPAK tert-butyl-QD-AX column with separation factors of 1.32 and 1.23, respectively. Concerning enantiomeric excess, an ee of 99.3% was determined for compound (R)-1, 99.99% for (S)-1, and 99.2% for (R)-2. The same elution order, (S)-before (R)-enantiomer, was also observed for AQC-derivatized compounds 3 and 4 using the unmodified QN-AX column, providing separation factors of 1.14 and 1.38, respectively. The determined ee values were 97.2% for compound (R)-3 and 98.8% for (R)-4 after crystallization (values for mother liquor and before crystallization: 76.9 and 92.2%). Although compound 6 was an analogue of compound 2, an elution order of (R) before (S) was observed with a separation factor of 1.23 and an ee value of 91.6% after crystallization (values for mother liquor and before crystallization: 56.3 and 83.1%) using AQC derivatization and separation on an unmodified QN-AX column. A control experiment for compound 2 derivatized with AQC and separation on the same unmodified QN-AX column showed the same elution order, (R) before (S), as observed for compound 6; however, no baseline separation could be achieved under standard test conditions (data not shown). The deviation in the elution order was the result of using different derivatization reagents combined with different chiral selector types (QN-AX vs QD-AX) and selector modifications (tert-butyl type vs unmodified CSP) for enantiomer separation. . Cyclohexene (598 mg, 0.74 mL, 7.28 mmol, 4 equiv) was added to a solution of H 3 B × Me 2 S (277 mg, 0.35 mL, 3.64 mmol, 2 equiv) in freshly distilled dry 1,2-dimethoxyethane (DME, 5.5 mL) under an argon atmosphere at 0°C. The reaction mixture was stirred for 15 min at 0°C and 1 h at room temperature. The resulting suspension of dicyclohexylborane 23 was again cooled at 0°C. Racemic 1-azido-3-butenylphosphonate (±)-8 18 (475 mg, 1.82 mmol) dissolved in dry DME (1 mL) was added. After stirring for 1 h at 0°C and 2 h at room temperature, the reaction was quenched with concd HCl (2 mL) and water (5 mL). The organic phase was removed, and the aq one was concentrated under reduced pressure. The residue was refluxed with a mixture of concd HCl (8 mL) and water (5 mL) for 18 h. The solution was cooled and concentrated under reduced pressure. The residue was dried over KOH in a vacuum desiccator and purified by cation-exchange chromatography (Dowex 50W × 8, H + , elution with water). Racemic nosylate (±)-11 18 (993 mg, 2.36 mmol) was dissolved in a mixture of methanol (5 mL) and CH 2 Cl 2 (5 mL). Ozone was bubbled through the stirred solution at −78°C until the blue color persisted. Excess ozone was removed by passing air through the solution. NaBH 4 (107 mg, 2.83 mmol, 1.2 equiv, dissolved in 1 mL of ethanol) was added and stirring was continued for 2.5 h at room temperature. The reaction mixture was concentrated under reduced pressure. The residue was dissolved in water (10 mL) and EtOAc (10 mL). The organic layer was separated, and the aq one was extracted with EtOAc (2 × 10 mL). The combined organic layers were dried (Na 2 
(±)-and (R)-(+)-Isoxazolidin-3-ylphosphonic Acid [(±)-and (R)-2].
Racemic phthalimidooxyphosphonate (±)-13 (762 mg, 1.34 mmol) was dissolved in iPrOH (4 mL) and heated and stirred at 60°C after addition of N 2 H 4 × H 2 O (334 mg, 6.68 mmol, 0.33 mL). A crystalline solid was formed rapidly. After 1 h, the solvent was removed at reduced pressure (1 mbar). Diisopropyl ether was added, and the residue was converted to a paste by stirring and breaking up the lumps with a spatula. The mixture was filtered through a Celite pad with suction and carefully washed with iPr 2 O. The filtrate was concentrated under reduced pressure. The oily, faint yellow residue (355 mg) was mixed with AcOH/HBr 24 (7 mL, 30%) under argon at room temperature and stirred for 16 h. Volatile compounds were removed under vacuum (1 mbar). under argon atmosphere. A solution of DIBALH (33 mL, 1 M, toluene) was added dropwise over 10 min. 28 After 2 h of additional stirring at −78°C, diisopropyl trimethylsilyl phosphite (7.150 g, 30 mmol) was added. The cooling bath was removed and the reaction mixture was stirred at room temperature for 18 h. HCl (2 M, 10 mL, exothermic!) was added dropwise, and after 10 min, more HCl (90 mL) was added and stirring was continued for 30 min (TLC: the silylated hydroxyphosphonate should be absent). The organic phase was separated and the aq one was extracted with EtOAc (3 × 50 mL). The combined organic layers were washed with brine, dried (MgSO 4 ), and concentrated under reduced pressure. The residue was purified by flash chromatography (hexanes/EtOAc, 1:3; R f 0.24) to give racemic α-hydroxyphosphonate (±)-20 (6.558 g, 84%) as a colorless oil.
IR ( , dry pyridine (4.556 g, 57.6 mmol, 4.649 mL, 3 equiv) was added, and the solution was stirred for 10 min. Chloroacetic anhydride (4.924 g, 28.8 mmol, 1.5 equiv) dissolved in dry CH 2 Cl 2 (16 mL) was added and stirring was continued at 0°C. 38 After 2.5 h (TLC monitoring), when the starting material was consumed, the reaction was quenched with water (4 mL), and stirring was continued for 5 min before more water (20 mL) was added. The organic phase was separated, and the aqueous one was extracted with EtOAc (30 mL). The combined organic phases were washed with HCl (30 mL, 2 M), water (10 mL), saturated aqueous solution of NaHCO 3 (20 mL), dried (MgSO 4 ), and concentrated under reduced pressure. 3 mmol) was dissolved in a mixture of t-BuOMe and hexanes (36 mL, 1:1) and phosphate buffer (25 mM, 120 mL).
14 After the pH had been adjusted to 7.0 using the autotitrator, lipase from Thermomyces lanuginosus (0.4 mL, ≥100 000 U/g, [3.1.1.3], Sigma) was added. The mixture was vigorously stirred at room temperature, and pH of 7.0 was maintained by the addition of NaOH (0.5 M). At a conversion of 40% by consumption of the base (13.04 mL), the pH was brought to 4 by the addition of HCl (2 M). The reaction mixture was extracted with EtOAc (3 × 100 mL). The combined organic phases were washed with a saturated aq solution of NaHCO 3 (50 mL), dried (MgSO 4 518 g, 2. 08 mL, 15.0 mmol, 1.5 equiv) and CH 3 SO 2 Cl (1.489 g, 1.01 mL, 13.0 mmol, 1.3 equiv, dissolved in 5 mL of dry CH 2 Cl 2 ) were added to a stirred solution of racemic 3-bromo-1-hydroxypropylphosphonate (±)-27 (3.031 g, 10 mmol) in dry CH 2 Cl 2 (35 mL) at 0°C under Ar. After 1 h, the cooling bath was removed, and water (10 mL) was added. Stirring was continued for 10 min, before the organic phase was separated, and the aq one was extracted with CH 2 Cl 2 (2 × 15 mL). The combined organic layers were washed with HCl (2 M, 10 mL), washed with water (5 mL), then dried (MgSO 4 ), and concentrated under reduced pressure. The residue was purified by flash chromatography (heptanes/ EtOAc, 1:1, R f 0.37) to yield mesyloxyphosphonate (±)-28b , and NaOH (4 mL, 20 w/v %) were added to mesyloxyphosphonate (±)-28b (870 mg, 2.28 mmol) at 0°C. The mixture was stirred vigorously. After 1 h, a sample for the 31 P NMR spectrum was withdrawn and diluted with CDCl 3 . As only the starting product was detected, the cooling bath was replaced by a water bath of 19°C (the temperature was not allowed to surpass 20°C). After 2 h at 19−20°C, another sample was withdrawn for 31 P NMR spectroscopy. This time, beside the resonance for the starting material (δ P 15.3), a new signal (δ P 16.1) appeared which was assigned to the hydrazine derivative (±)-29b (their ratio was 1.0:0.54). Within 5 h at 19−20°C, the starting material decreased to 1%. Now, the reaction mixture was worked up. EtOAc (20 mL) and a saturated aq solution of NaHCO 3 (20 mL) were added. The organic phase was removed, and the aq one was extracted with EtOAc (2 × 10 mL). The combined organic layers were washed with HCl (10 mL, 1 M), 34 Enzyme activity was measured at 35°C as the P5C-dependent oxidation of NADH. The assay mixture contained 50 mM Tris-HCl buffer, pH 7.5, 0.4 mM NADH, 2 mM DL−P5C and 1 mM MgCl 2 in a final volume of 1 mL. A limiting amount of enzyme (about 0.2 nkat) was added to the prewarmed mixture, and the decrease in absorbance at 340 nm was determined for up to 10 min by continuous monitoring of the sample. Activity was calculated on the assumption of an extinction coefficient for NADH of 6220 M −1 cm −1
. The concentrations causing 50% inhibition (IC 50 ) of P5C reductase activity and their confidence intervals were estimated by nonlinear regression analysis using Prism 6 for Windows (version 6.07; GraphPad Software Inc., San Diego, CA, USA).
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